Calcium channel and β-receptor antagonists and agonists in MG

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 785-788

  Matell, Georg ^a,b   Bjelak, Sapko ^a,b   Jonkers, Iris ^a,c   Pirskanen, Ritva ^a,b   Van Vliet, Jorine ^a,c   Swerup, Christer ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL; CALCIUM GLUBIONATE; PROPRANOLOL; TERBUTALINE; VERAPAMIL;

CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE FATIGUE; MUSCLE FUNCTION; MYASTHENIA GRAVIS; NERVE STIMULATION; NEUROPHYSIOLOGY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0031928677     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11019.x     Document Type: Conference Paper

References (11)

1. ADAMS, S. L., J. MATHEWS & L. C. GRAMMAR. 1984. Drugs that may exacerbate myasthenia gravis. Ann. Emerg. Med. 13: 532-538.
2. ARGOV, Z. & F. L. MASTAGLIA. 1979. Disorders of neuromuscular transmission caused by drugs. N. Engl. J. Med. 301: 409-413.
3. BARAR, F. S. K. & B. R. MADAN. 1973. Effect of some beta adrenoceptor blocking agents on skeletal neuromuscular transmission and motor coordination. Indian J. Med. Res. 1: 1054-1061.
4. CHANG, C. C., S-O. LIN, S. J. HONG & L. C. CHIOU. 1988. Neuromuscular block by verapamil and diltiazem and inhibition of acetylcholine release. Brain Res. 454: 332-339.
5. CONFAVREUX, C., N. CHARLES & G. AIMARD. 1990. Fulminant myasthenia gravis soon after initiation of acebutolol therapy. Eur. Neurol. 30: 279-281.
6. KÓMÁR, J. & M. SZALAY SZÉL. 1987. Myasthenische Episode nach Einnahme grosser Mengen Betablocker. Fortschr. Neurol. Psychiatr. 55: 201-202.
7. LEE, S. C. & S. T. HO. 1987. Acute effects of verapamil on neuromuscular transmission in patients with myasthenia gravis. Proc. Natl. Sci. Counc. Repub. China Part B 11: 307-312.
8. NOGUÉS, M. A. & A. RIVERO. 1993. Arterial hypertension, nifedipine, and myasthenia gravis. Muscle Nerve 16: 797.
9. SHAIVITZ, S. A. 1979. Timolol and myasthenia gravis. JAMA 242: 1611-1612.
10. SWASH, M. & D. A. INGRAM. 1992. Adverse effect of verapamil in myasthenia gravis. Muscle Nerve 15: 396-398.
11. JONKERS, I., C. SWERUP, R. PIRSKANEN, S. BJELAK & G. MATELL. 1996. Acute effects of intravenous injection of beta-adrenoreceptor and calcium channel antagonists. Muscle Nerve 19: 959-965.